Anti-inflammatory diet as add-on therapy in inflammatory bowel disease - INSIDE

Wageningen Universiteit0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年4月15日

适应症

试验速览

暂无简介。

•- Diagnosis of Crohn's disease or ulcerative colitis (total or left-sided colitis) made by gastroenterologist and histologically proven
•- Between 18-75 years of age
•- Mild disease activity based on CDAI * 150 or SCCAI * 3
•- Stable medical therapy for * 2 months
•- Signed informed consent

•- Unwilling or unable to visit the Human Nutrition Research Unit five times per week during the intervention period
•- Unwilling to strictly follow a diet for four weeks
•- Participation in another intervention study
•- Adherence to a vegan lifestyle
•- Intending to make lifestyle changes during the duration of the study
•- History of total or partial bowel resection
•- Use of biologicals (e.g. infliximab, adalimumab, golumimab, ustekinumab, vedolizumab)
•- More supplement use than the recommended dietary allowance
•- Not allowing to inform the treating gastroenterologist about the participation
•- Being an employee or student of Wageningen University, division of Human Nutrition and Health

发起方